Trial Profile
DD-723 Phase III Clinical Trial - Confirmatory Study in Subjects with Breast Tumor -
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Perflubutane (Primary)
- Indications Breast cancer; Male breast cancer
- Focus Diagnostic use; Registrational
- Sponsors Daiichi Sankyo Company
- 24 May 2016 New trial record